AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figure holds a giant arrow

Finding freedom as a physician through entrepreneurship

| 5 Min Read
Patient in a wheelchair

Catch up on Medicaid work requirements’ medical frailty exemption

| 4 Min Read
Physician working at a computer

Switching well-being surveys to uncover physician burnout drivers

| 8 Min Read
Doctor and three large vials surrounded by medical icons

What doctors wish patients knew about iron deficiency

| 10 Min Read